Application of Trial Simulation in the Design of a Prospective Study for Concentration-QTc Analysis in Support of a Thorough QT Study Waiver

Author:

Zhu PeijuanORCID,Hsu Chyi-Hung,Hu Chuanpu,Wong Peggy,Sy Sherwin K. B.,Nandy Partha,Zhou Honghui

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Reference24 articles.

1. Research C for DE and. E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs Questions and Answers (R3) Guidance for Industry [Internet]. US Food Drug Adm. 2019 [cited 2020 Jan 24]. Available from: http://www.fda.gov/regulatory-information/search-fda-guidance-documents/e14-clinical-evaluation-qtqtc-interval-prolongation-and-proarrhythmic-potential-non-antiarrhythmic-1

2. Darpo B, Garnett C, Keirns J, Stockbridge N. Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14. Drug Saf [Internet]. 2015 [cited 2019 Jul 15];38:773–80. Available from: https://doi.org/10.1007/s40264-015-0325-5

3. Ferber G. Data-based simulation studies to assess the power of detecting moxifloxacin QTc response using concentration-QTc in small phase-1 studies [Internet]. 2011. Available from: https://cardiac-safety.org/wp-content/uploads/2014/11/Ferber-Washington-2012.pdf

4. The IQ-CSRC Prospective Clinical Phase 1 Study: “Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study?” - Darpo - 2014 - Annals of Noninvasive Electrocardiology - Wiley Online Library [Internet]. [cited 2019 Jul 15]. Available from: https://doi.org/10.1111/anec.12128

5. Results From the IQ-CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase - Darpo - 2015 - Clinical Pharmacology & Therapeutics - Wiley Online Library. [cited 2019 Jul 15]; Available from: https://doi.org/10.1002/cpt.60

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3